US Stock MarketDetailed Quotes

MLTX MoonLake Immunotherapeutics

Watchlist
  • 55.370
  • +0.970+1.78%
Close Dec 27 16:00 ET
  • 55.370
  • 0.0000.00%
Post 16:00 ET
3.49BMarket Cap-43.60P/E (TTM)

MoonLake Immunotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-173.22%-25.27M
-129.38%-27.89M
-65.64%-14.95M
23.47%-42.78M
-6.45%-12.34M
1.08%-9.25M
41.43%-12.16M
36.38%-9.02M
-55.89M
-11.6M
Net income from continuing operations
-210.81%-36.11M
-100.42%-24.76M
-14.38%-13.98M
31.67%-44.08M
52.10%-7.89M
21.18%-11.62M
29.07%-12.35M
23.05%-12.22M
---64.51M
---16.47M
Operating gains losses
91.09%-2.13K
97.99%-272
97.95%-272
-128.04%-85.25K
-145.21%-34.51K
-131.40%-23.96K
-118.18%-13.51K
-117.22%-13.27K
--304.03K
--76.34K
Depreciation and amortization
888.30%32.52K
754.73%28.11K
593.40%22.81K
6.47%13.16K
0.00%3.29K
-0.09%3.29K
0.03%3.29K
32.23%3.29K
--12.36K
--3.29K
Other non cash items
9,305.06%683.94K
5,310.86%333.47K
75.81%171.65K
119.47%484.76K
71.57%388.4K
71.87%-7.43K
-61.57%6.16K
1,902.28%97.63K
--220.88K
--226.38K
Change In working capital
752.81%8.28M
-309.62%-5.32M
-636.93%-2.84M
-293.55%-6.22M
-425.97%-6.42M
-64.71%971.22K
78.06%-1.3M
239.72%529.72K
---1.58M
--1.97M
-Change in receivables
-623.10%-730.25K
25.02%-180.94K
-172.15%-439.01K
-1,128.49%-839.73K
-187.66%-336.11K
-132.22%-100.99K
-1,083.98%-241.32K
62.73%-161.32K
---68.36K
--383.41K
-Change in prepaid assets
128.53%1.49M
-824.40%-8.18M
-175.44%-832.51K
-132.43%-6.35M
-2,507.34%-7.22M
2.62%650.1K
68.59%-884.52K
230.15%1.1M
---2.73M
--299.73K
-Change in payables and accrued expense
1,562.64%7.68M
2,607.56%3.35M
-210.83%-1.16M
-8.41%1.26M
-9.51%1.3M
-78.64%461.67K
95.73%-133.76K
-141.45%-373.74K
--1.37M
--1.44M
-Change in other current assets
--1
---1
---5.44K
---65.51K
---65.51K
--0
--0
--0
--0
----
-Change in other current liabilities
-275.69%-148.63K
-705.97%-317.91K
-944.62%-405.58K
-45.82%-222.26K
---104.43K
---39.56K
---39.45K
---38.83K
---152.43K
----
Cash from discontinued investing activities
Operating cash flow
-173.22%-25.27M
-129.38%-27.89M
-65.64%-14.95M
23.47%-42.78M
-6.45%-12.34M
1.08%-9.25M
41.43%-12.16M
36.38%-9.02M
---55.89M
---11.6M
Investing cash flow
Cash flow from continuing investing activities
133.42%58.28M
-792.19%-87.74M
-246.60%-28.8M
22.13%-25.18M
1,080.30%116.87M
-312.96%-174.38M
633,802,550.00%12.68M
122,826.62%19.65M
-32.34M
9.9M
Net PPE purchase and sale
---132.19K
--0
---211.77K
-1,677.96%-284.63K
-28,463,300.00%-284.63K
--0
--0
--0
---16.01K
---1
Net investment purchase and sale
133.50%58.41M
-792.19%-87.74M
-245.52%-28.59M
22.97%-24.9M
1,083.17%117.15M
-312.96%-174.38M
--12.68M
--19.65M
---32.32M
--9.9M
Cash from discontinued investing activities
Investing cash flow
133.42%58.28M
-792.19%-87.74M
-246.60%-28.8M
22.13%-25.18M
1,080.30%116.87M
-312.96%-174.38M
633,802,550.00%12.68M
122,826.62%19.65M
---32.34M
--9.9M
Financing cash flow
Cash flow from continuing financing activities
183.1K
0
50.98M
300.78%479.7M
749,475.71%28.42M
0
331.09%451.29M
0
119.69M
3.79K
Net issuance payments of debt
----
----
----
--0
----
----
----
----
---15M
--0
Net common stock issuance
--0
--0
--52.54M
--482.45M
--31.17M
--0
--451.29M
--0
--0
--0
Proceeds from stock option exercised by employees
----
----
----
--0
--0
----
----
----
--3.79K
----
Net other financing activities
--91.8K
--0
---1.56M
-102.04%-2.75M
----
----
----
----
--134.69M
--0
Cash from discontinued financing activities
Financing cash flow
--183.1K
--0
--50.98M
300.78%479.7M
749,475.71%28.42M
--0
331.09%451.29M
--0
--119.69M
--3.79K
Net cash flow
Beginning cash position
-31.69%342.79M
814.52%458.44M
1,042.04%451.17M
391.43%39.51M
672.16%318.17M
441.26%501.79M
467.45%50.13M
391.43%39.51M
--8.04M
--41.2M
Current changes in cash
118.08%33.19M
-125.59%-115.63M
-31.99%7.23M
1,208.84%411.74M
7,962.69%132.94M
-256.02%-183.63M
438.34%451.8M
1,225.00%10.62M
--31.46M
---1.69M
Effect of exchange rate changes
-6,600.94%-325.44K
88.30%-16.9K
8,786.92%46.48K
-981.81%-75.31K
881.32%64.74K
-93.26%5.01K
-183.38%-144.52K
91.77%-535
--8.54K
---8.29K
End cash Position
18.07%375.66M
-31.69%342.79M
814.52%458.44M
1,042.04%451.17M
1,042.04%451.17M
672.16%318.17M
441.26%501.79M
467.45%50.13M
--39.51M
--39.51M
Free cash flow
-174.65%-25.41M
-129.38%-27.89M
-67.99%-15.16M
22.98%-43.06M
-8.91%-12.63M
1.08%-9.25M
41.43%-12.16M
36.46%-9.02M
---55.91M
---11.6M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -173.22%-25.27M-129.38%-27.89M-65.64%-14.95M23.47%-42.78M-6.45%-12.34M1.08%-9.25M41.43%-12.16M36.38%-9.02M-55.89M-11.6M
Net income from continuing operations -210.81%-36.11M-100.42%-24.76M-14.38%-13.98M31.67%-44.08M52.10%-7.89M21.18%-11.62M29.07%-12.35M23.05%-12.22M---64.51M---16.47M
Operating gains losses 91.09%-2.13K97.99%-27297.95%-272-128.04%-85.25K-145.21%-34.51K-131.40%-23.96K-118.18%-13.51K-117.22%-13.27K--304.03K--76.34K
Depreciation and amortization 888.30%32.52K754.73%28.11K593.40%22.81K6.47%13.16K0.00%3.29K-0.09%3.29K0.03%3.29K32.23%3.29K--12.36K--3.29K
Other non cash items 9,305.06%683.94K5,310.86%333.47K75.81%171.65K119.47%484.76K71.57%388.4K71.87%-7.43K-61.57%6.16K1,902.28%97.63K--220.88K--226.38K
Change In working capital 752.81%8.28M-309.62%-5.32M-636.93%-2.84M-293.55%-6.22M-425.97%-6.42M-64.71%971.22K78.06%-1.3M239.72%529.72K---1.58M--1.97M
-Change in receivables -623.10%-730.25K25.02%-180.94K-172.15%-439.01K-1,128.49%-839.73K-187.66%-336.11K-132.22%-100.99K-1,083.98%-241.32K62.73%-161.32K---68.36K--383.41K
-Change in prepaid assets 128.53%1.49M-824.40%-8.18M-175.44%-832.51K-132.43%-6.35M-2,507.34%-7.22M2.62%650.1K68.59%-884.52K230.15%1.1M---2.73M--299.73K
-Change in payables and accrued expense 1,562.64%7.68M2,607.56%3.35M-210.83%-1.16M-8.41%1.26M-9.51%1.3M-78.64%461.67K95.73%-133.76K-141.45%-373.74K--1.37M--1.44M
-Change in other current assets --1---1---5.44K---65.51K---65.51K--0--0--0--0----
-Change in other current liabilities -275.69%-148.63K-705.97%-317.91K-944.62%-405.58K-45.82%-222.26K---104.43K---39.56K---39.45K---38.83K---152.43K----
Cash from discontinued investing activities
Operating cash flow -173.22%-25.27M-129.38%-27.89M-65.64%-14.95M23.47%-42.78M-6.45%-12.34M1.08%-9.25M41.43%-12.16M36.38%-9.02M---55.89M---11.6M
Investing cash flow
Cash flow from continuing investing activities 133.42%58.28M-792.19%-87.74M-246.60%-28.8M22.13%-25.18M1,080.30%116.87M-312.96%-174.38M633,802,550.00%12.68M122,826.62%19.65M-32.34M9.9M
Net PPE purchase and sale ---132.19K--0---211.77K-1,677.96%-284.63K-28,463,300.00%-284.63K--0--0--0---16.01K---1
Net investment purchase and sale 133.50%58.41M-792.19%-87.74M-245.52%-28.59M22.97%-24.9M1,083.17%117.15M-312.96%-174.38M--12.68M--19.65M---32.32M--9.9M
Cash from discontinued investing activities
Investing cash flow 133.42%58.28M-792.19%-87.74M-246.60%-28.8M22.13%-25.18M1,080.30%116.87M-312.96%-174.38M633,802,550.00%12.68M122,826.62%19.65M---32.34M--9.9M
Financing cash flow
Cash flow from continuing financing activities 183.1K050.98M300.78%479.7M749,475.71%28.42M0331.09%451.29M0119.69M3.79K
Net issuance payments of debt --------------0-------------------15M--0
Net common stock issuance --0--0--52.54M--482.45M--31.17M--0--451.29M--0--0--0
Proceeds from stock option exercised by employees --------------0--0--------------3.79K----
Net other financing activities --91.8K--0---1.56M-102.04%-2.75M------------------134.69M--0
Cash from discontinued financing activities
Financing cash flow --183.1K--0--50.98M300.78%479.7M749,475.71%28.42M--0331.09%451.29M--0--119.69M--3.79K
Net cash flow
Beginning cash position -31.69%342.79M814.52%458.44M1,042.04%451.17M391.43%39.51M672.16%318.17M441.26%501.79M467.45%50.13M391.43%39.51M--8.04M--41.2M
Current changes in cash 118.08%33.19M-125.59%-115.63M-31.99%7.23M1,208.84%411.74M7,962.69%132.94M-256.02%-183.63M438.34%451.8M1,225.00%10.62M--31.46M---1.69M
Effect of exchange rate changes -6,600.94%-325.44K88.30%-16.9K8,786.92%46.48K-981.81%-75.31K881.32%64.74K-93.26%5.01K-183.38%-144.52K91.77%-535--8.54K---8.29K
End cash Position 18.07%375.66M-31.69%342.79M814.52%458.44M1,042.04%451.17M1,042.04%451.17M672.16%318.17M441.26%501.79M467.45%50.13M--39.51M--39.51M
Free cash flow -174.65%-25.41M-129.38%-27.89M-67.99%-15.16M22.98%-43.06M-8.91%-12.63M1.08%-9.25M41.43%-12.16M36.46%-9.02M---55.91M---11.6M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Advanced Micro Devices
AMD
+0.10%
ASML Holding
ASML
-0.32%
Meta Platforms
META
-0.59%
Cisco
CSCO
-0.62%
Intel
INTC
-0.68%

Unlock the Full List